Physician profile
David Peltzer
NPI 1053370288
$7,874.22
in general payments reported to CMS, 2019-2025
52 companies · $1,297 in 2025
The $1,297 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,658 · 2020: $863 · 2021: $840 · 2022: $1,322 · 2023: $963 · 2024: $931 · 2025: $1,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,016 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,015.88 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,142.06 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $990.16 | 2019-2025 | Prolia, Evenity, Prolia |
| Astrazeneca Pharmaceuticals Lp | $779.44 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $704.46 | 2019-2025 | |
| Abbvie INC. | $401.09 | 2019-2025 | |
| Lilly USA, LLC | $396.33 | 2019-2025 | Mounjaro, Zepbound |
| Dexcom, INC. | $296.34 | 2021-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.73 | 2020-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $277.25 | 2019-2025 | |
| Abbott Laboratories | $248.40 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Bayer Healthcare Pharmaceuticals INC. | $242.42 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $241.07 | 2019-2022 | |
| Glaxosmithkline, LLC. | $180.68 | 2019-2023 | Shingrix, Arexvy |
| Amneal Pharmaceuticals LLC | $140.50 | 2023-2025 | Unithroid |
| Medtronic, INC. | $133.88 | 2021-2023 | Intellis Adaptivestim |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Peltzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.